# LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
Canonical URL: https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026-b7240d53
Ticker: LMAT
Company: LeMaitre Vascular
Source: LeMaitre Vascular
Published: 2026-04-14 20:54 EST
## Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026...

## Article Body
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here . All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com .

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
## Recent Company News
- 2026-07-14 21:43 EST — [LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026-269755ae) — Source: LeMaitre Vascular
- 2026-05-20 20:25 EST — [LeMaitre to Participate at Upcoming Investor Conferences in June](https://biopharmsignal.com/news/LMAT/lemaitre-to-participate-at-upcoming-investor-conferences-in-june-a4d71e69) — Source: LeMaitre Vascular
- 2026-05-07 21:15 EST — [LeMaitre to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/LMAT/lemaitre-to-present-at-the-bank-of-america-healthcare-conference-3f9a75f1) — Source: LeMaitre Vascular
- 2026-05-05 20:05 EST — [LeMaitre Q1 2026 Financial Results](https://biopharmsignal.com/news/LMAT/lemaitre-q1-2026-financial-results-1a3119ae) — Source: LeMaitre Vascular
- 2026-04-14 20:54 EST — [LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026-b7240d53) — Source: LeMaitre Vascular
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)